Lincoln Pharmaceuticals standalone net profit declines 57.59% in the June 2017 quarter

Sales rise 14.56% to Rs 87.19 crore

Net profit of Lincoln Pharmaceuticals declined 57.59% to Rs 4.50 crore in the quarter ended June 2017 as against Rs 10.61 crore during the previous quarter ended June 2016. Sales rose 14.56% to Rs 87.19 crore in the quarter ended June 2017 as against Rs 76.11 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales87.1976.11 15 OPM %6.6617.38 -PBDT7.2015.03 -52 PBT6.2414.07 -56 NP4.5010.61 -58

Powered by Capital Market - Live News